The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

October 23, 2015 – Proove Release: Proove Partners with USC to Conduct Research

Proove Biosciences, a commercial and research leader in personalized medicine, is excited to announce their partnership with the Keck Medicine of the University of Southern California(USC) Pain Center to study the genetics of chronic pain. The T.R.O.J.A.N. Study...

May 2, 2017 – Proove Release: Proove CEO to Speak at 5 th Annual Medical Device Forum

Award-Winning Entrepreneur Brian Meshkin will speak at the 10X Medical Device Conference in San Diego IRVINE, Calif., May 2, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its founder and Chief Executive Officer, Brian Meshkin, will speak at the...

July 14, 2015 – Proove Release: Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

Irvine, CA (PRWEB) July 14, 2015 Proove Biosciences, a commercial and research leader in Personalized Medicine, recently presented data on three ground-breaking scientific studies at the Neurological Disorders Summit in San Francisco, CA. The Neurological Disorders...

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

Proove Biosciences Closes on the Acquisition of Pain Genetics Firm Algynomics Proove Biosciences, Inc. today announced it has closed on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics platform and its patient...

August 2, 2017 | Proove Release: 7 th Published Peer-Reviewed Study in Last 7 Months Supports Proove Technology to Predict Opioid Abuse

New Peer-Reviewed Prospective Study Shows that Proove Opioid Risk® Profile Results in Better Pain Management Decisions Providing a 50% Reduction in Pain IRVINE, Calif., Aug. 2, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces yet another new...

March 23, 2017 – Proove Release: Proove CEO to Speak at 8 th Annual Life Sciences CEO Forum

Brian Meshkin will moderate a panel on "Delivering on the Promise of Precision Medicine" and participate in a panel on "The Convergence of Technology & Healthcare" IRVINE, Calif., March 23, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces that its founder and...

April 7, 2015 – Proove Release: Proove Launches Opioid Response Test

(PRWEB) APRIL 07, 2015 Proove Biosciences a commercial and research leader in Personalized Medicine, is excited to announce the launch of Proove Opioid Response - the world’s first clinical laboratory test to predict responders to opioid pain medications. Building on...

June 21, 2017 – Proove Release: Large Published Peer-Reviewed Clinical Utility Study Shows Pain Reduction

Study Shows Over 90% of Patients Experienced Significant Pain Reduction without Opioid Abuse and Physicians Believe Technology Provides Patient Benefits to Help Reduce Opioid Epidemic IRVINE, Calif., June 21, 2017 /PRNewswire/ -- Proove® Biosciences,...

March 16, 2017 – Proove Release: Key Opinion Leaders Present Precision Medicine Research from Proove at American Academy of Pain Medicine Meeting

Proove continues its leadership of precision pain medicine presenting over 100 studies at major medical meetings outlining breakthrough precision medicine research over the past 5 years IRVINE, Calif., March 16, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. is...

March 15, 2017 – Proove Release: Published Case Study Shows How Leading Orthopedic Surgeon Uses Proove Technology to Improve Patient Care

Post-Operative Orthopedic Surgery Study Using Precision Medicine Platform Published in the Journal of Medical Case Reports Demonstrates How Proove Profiles Are Used to Improve Outcomes IRVINE, Calif., March 15, 2017 /PRNewswire/ -- Proove Biosciences, Inc. announces...

Video’s

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

Get Instant Access to Updates to The Truth about Proove Bio